Google
×
For patients with severe hepatic impairment (Child Pugh-C), reduce the VERZENIO dosing frequency to once daily [see. Use in Specific Populations (8.7) and ...
See full prescribing information for VERZENIO. VERZENIO™ (abemaciclib) tablets, for oral use. Initial U.S. Approval: 2017. --------- ...
Verzenio is an oral medication for certain people with HR+, HER2- metastatic breast cancer (MBC).
PACKAGE LEAFLET. Page 43. 43. Package leaflet: Information for the patient. Verzenios 50 mg film-coated tablets. Verzenios 100 mg film-coated tablets. Verzenios ...
Apr 4, 2019 · Abemaciclib is a type of drug called a kinase inhibitor. It works by stopping cancer cells from dividing and growing. This may slow the ...
People also ask
Mar 3, 2023 · The FDA approved an expanded indication for abemaciclib (Verzenio) in combination with endocrine therapy for the adjuvant treatment of adult patients.
Jun 9, 2022 · AUSTRALIAN PI – VERZENIO™ (ABEMACICLIB) TABLET. 1 NAME OF THE MEDICINE. Abemaciclib. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION. Abemaciclib ...
Missing: insert | Show results with:insert
Dosage with Hepatic Impairment: Hepatic Impairment. Abemaciclib Dose. Mild or moderate impairment (Child-. Pugh class A or B). No dosage adjustment necessary.
Missing: insert | Show results with:insert
What is abemaciclib? 2. Who might be offered abemaciclib? 3. How does abemaciclib work? 4. How is abemaciclib given? 5. Common side effects of abemaciclib.
Verzenios is a cancer medicine used to treat women with breast cancer that is advanced or has spread to other parts of the body (metastatic).
Missing: insert | Show results with:insert